1
Role of LDH as a Predictor of Treatment Outcomes in Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:November 7, 2017Unknown status
Hepatocellular Carcinoma: 2136 Clinical Trials, Page 1 of 22
Hide Studies Not Open or Pending
2
Determination of Autonomic Responses to the Exposure of Low Energy Electromagnetic Fields With Frequency Modulation in Patients With Advanced Hepatocellular Carcinoma and Healthy Individuals.
Condition(s):Hepatocellular CarcinomaLast Updated:August 3, 2018Recruiting
3
Xihuang Capsules Prevention of Recurrence in Patients With Hepatocellular Carcinoma After Hepatectomy
Condition(s):Hepatocellular CarcinomaLast Updated:March 22, 2015Recruiting
4
Identification of Specific Modulation Frequencies in Hepatitis B Carriers With and Without Hepatocellular Carcinoma
Condition(s):Hepatitis; Hepatocellular CarcinomasLast Updated:September 10, 2015Completed
5
Circulating Cell-free DNA-based Epigenetic Biomarker mSEPT9 for Hepatocellular Carcinoma Detection in Cirrhosis
Condition(s):Hepatocellular Carcinoma; CirrhosisLast Updated:February 15, 2018Recruiting
6
Hepatitis B Virus HBeAg-negative Genotype D Patients and Hepatocellular Carcinoma
Condition(s):Hepatocellular Carcinoma; Hepatitis BLast Updated:December 31, 2013Completed
7
Study on Recurrence Monitoring of Hepatocellular Carcinoma With 5-Hydroxymethylcytosine Test
Condition(s):Hepatocellular CarcinomaLast Updated:April 9, 2018Recruiting
8
Frequency of Circulating Tumor Cells (CTCs) and Amount of Cell-free DNA (cfDNA) in Cirrhotic Patients With Hepatocellular Carcinoma (HCC)
Condition(s):Hepatocellular CarcinomaLast Updated:October 22, 2019Completed
9
The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study
Condition(s):Chronic Hepatitis C; Chronic Hepatitis BLast Updated:January 27, 2015Withdrawn
10
Annexin A2 as a Novel Diagnostic Marker in Hepatocellular Carcinoma
Condition(s):Hepatocellular Carcinoma (HCC)Last Updated:September 3, 2015Completed
11
[68Ga]DOTATATE-PET/MRI in Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:March 25, 2019Recruiting
12
Procalcitonin in Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:September 29, 2013Completed
13
Circulating Tumor Cell Genome in Peripheral Blood From Hepatocellular Carcinoma Patients Under Radiotherapy
Condition(s):Circulating Neoplastic Cells; Adverse Effect of Radiation Therapy; Fatal OutcomeLast Updated:February 3, 2015Unknown status
14
Novel Gallium Imaging in Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:December 31, 2018Active, not recruiting
15
Recurrence of Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:September 29, 2013Completed
16
Probiotics in the Prevention of Hepatocellular Carcinoma in Cirrhosis
Condition(s):Microbiota; Hepatocellular Carcinoma; CirrhosisLast Updated:February 25, 2019Not yet recruiting
17
Surgical Stages of Liver Cirrhosis In Patients With Hepatocellular Carcinoma
Condition(s):Hepatocellular Carcinoma; Liver CirrhosisLast Updated:August 29, 2019Recruiting
18
Study of Combined Sorafenib With Radiotherapy in Patients With Advanced Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:April 1, 2011Unknown status
19
Sorafenib in Hepatocellular Carcinoma Clinical Practice in Italy
Condition(s):Hepatocellular CarcinomaLast Updated:February 16, 2016Completed
20
Glypican 3-specific Chimeric Antigen Receptor Expressing T Cells for Hepatocellular Carcinoma (GLYCAR)
Condition(s):Hepatocellular CarcinomaLast Updated:September 9, 2019Recruiting
21
Natural History Study of Children and Adults With Fibrolamellar Hepatocellular Carcinoma
Condition(s):Hepatocellular Carcinoma; Hepatocellular CancerLast Updated:September 20, 2019Recruiting
22
AZD6244 and Sorafenib in Advanced Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:April 14, 2015Terminated
23
Role of Positron Emission Tomography in the Evaluation of Response to Sorafenib in Advanced Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:July 2, 2010Completed
24
The Effect of Fluorouracil Implants Regional Chemotherapy During the Surgical Treatment for Early Stage Hepatocellular Carcinoma
Condition(s):Early Stage Hepatocellular CarcinomaLast Updated:January 24, 2010Unknown status
25
Safety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Hepatocellular Carcinoma
Condition(s):Primary Hepatocellular CarcinomaLast Updated:October 22, 2012Terminated
26
STOPPER CHINA:With Tandem Microspheres in the Treatment of Localized Hepatocellular Carcinoma
Condition(s):Localized Hepatocellular CarcinomaLast Updated:September 18, 2019Active, not recruiting
27
The Safety and Efficacy of Deferoxamine for Treating Unresectable Hepatocellular Carcinoma
Condition(s):Hepatocellular Carcinoma Non-resectableLast Updated:February 20, 2019Recruiting
28
Magnetic Resonance With Gadoxetic Acid for the Diagnosis of Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Evaluation of Its Impact for the Non-invasive Diagnosis
Condition(s):Hepatocellular CarcinomaLast Updated:August 21, 2016Completed
29
Safety and Efficacy of Oncoxin in Hepatocellular Carcinoma (HCC)
Condition(s):Hepatocellular CarcinomaLast Updated:December 11, 2012Unknown status
30
68 Ga PSMA PET/MRI for Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:June 27, 2019Enrolling by invitation
31
Radiofrequency Ablation Combined With Recombinant Human Adenovirus Type 5 in the Treatment of Hepatocellular Carcinoma.
Condition(s):Hepatocellular CarcinomaLast Updated:October 15, 2019Recruiting
32
Sorafenib-RT in Treating Hepatocellular Carcinoma (SHEP)
Condition(s):Hepatocellular CarcinomaLast Updated:September 21, 2018Active, not recruiting
33
RALPPS Venus ALPPS for Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:November 30, 2015Unknown status
34
MicroRNAs as Diagnostic Biomarkers in Hepatocellular Carcinoma Among Somali Patients
Condition(s):Hepatocellular CarcinomaLast Updated:July 22, 2017Unknown status
35
No-touch RFA Versus Traditional RFA for Small Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:September 13, 2017Enrolling by invitation
36
Immunotherapy of Advanced Hepatitis B Related Hepatocellular Carcinoma With γδT Cells
Condition(s):Hepatocellular CarcinomaLast Updated:July 23, 2019Not yet recruiting
37
Carbon Ion Radiotherapy for the Treatment of Chinese Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:September 6, 2019Recruiting
38
Biomarker Analysis in Sorafenib Treated Hepatocellular Carcinoma Patients
Condition(s):Hepatocellular CarcinomaLast Updated:April 24, 2017Completed
39
18F-FluoroethylCholine Positron Emission Tomography: a Promising Diagnostic Tool for Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:September 10, 2014Unknown status
40
A Phase I Clinical Study on a New Oral Pentamidine Formulation in Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:March 11, 2016Completed
41
TCR-Redirected T Cell Infusions to Prevent Hepatocellular Carcinoma Recurrence Post Liver Transplantation
Condition(s):Hepatocellular CarcinomaLast Updated:March 21, 2016Recruiting
42
Cabozantinib toLERANCE Study in HepatoCellular Carcinoma (CLERANCE)
Condition(s):Hepatocellular CarcinomaLast Updated:October 21, 2019Recruiting
43
Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma ≤ 5 cm
Condition(s):Hepatocellular CarcinomaLast Updated:September 18, 2019Active, not recruiting
44
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:September 18, 2019Completed
45
A Study of CD147-targeted CAR-T by Hepatic Artery Infusions for Very Advanced Hepatocellular Carcinoma
Condition(s):Advanced Hepatocellular CarcinomaLast Updated:August 24, 2019Recruiting
46
Hepatic Resection Versus TACE+RFA for BCLC Stage B Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:December 4, 2015Recruiting
47
Non-invasive Prediction of Microvascular Invasion in Hepatocellular Carcinoma by Blood-Oxygen-Level Dependent Magnetic Resonance Imaging (BOLD MRI)
Condition(s):Hepatocellular CarcinomaLast Updated:September 28, 2017Completed
48
Transarterial Chemoembolization Prior to Transplantation for Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:April 10, 2019Terminated
49
Ipsilateral Liver Lobe Devascularization of the Large Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:June 8, 2018Recruiting
50
A Study to Evaluate Autologous CIK Cells in Patients With Hepatocellular Carcinoma After TACE, PEIT or RFA
Condition(s):Hepatocellular CarcinomaLast Updated:April 19, 2017Unknown status
51
A Study of Second-line Treatment With Apatinib After TACE in Advanced Hepatocellular Carcinoma Patients
Condition(s):Hepatocellular CarcinomaLast Updated:March 30, 2016Unknown status
52
STA-9090 in Patients With Advanced Hepatocellular Cancer
Condition(s):Hepatocellular CarcinomaLast Updated:April 23, 2018Completed
53
AFP Model and Liver Transplantation.
Condition(s):Liver Carcinoma; Liver Transplant DisorderLast Updated:December 14, 2018Completed
54
Stereotactic Body Radiation Therapy (SBRT) Hepatocellular Carcinoma (COLD 2)
Condition(s):Hepatocellular CarcinomaLast Updated:September 21, 2018Active, not recruiting
55
Laparoscopic Versus Open Liver Resection in the Treatment of Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:November 16, 2015Recruiting
56
By Developing a Radiomics Model to Predict the Prognosis of Patients With Hepatocellular Carcinoma After Microwave Ablation
Condition(s):Hepatocellular CarcinomaLast Updated:May 22, 2019Recruiting
57
Pembrolizumab (Keytruda) in Advanced Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:September 4, 2019Active, not recruiting
58
Clinical Trial of Radiotherapy in Treating Primary Hepatocellular Carcinoma
Condition(s):Primary Hepatocellular CarcinomaLast Updated:January 20, 2019Recruiting
59
Biomarker Analyses in Hepatocellular Carcinoma (HCC) Patients Treated With TheraSphere®
Condition(s):Hepatocellular CarcinomaLast Updated:May 1, 2019Recruiting
60
Risk Factors of Hepatocellular Carcinomas Developed on Non-fibrotic Liver: Case-control Study (NoFlic Study)
Condition(s):Hepatocellular CarcinomaLast Updated:February 21, 2019Completed
61
Efficacy and Safety of Apatinib Combined With TACE in Patients With Hepatocellular Carcinoma
Condition(s):Hepatocellular Carcinoma Refractory to Transcatheter Arterial ChemoembolizationLast Updated:April 26, 2018Not yet recruiting
62
Cetuximab in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:March 16, 2014Completed
63
Drug Monitoring of Sorafenib in Patients With Advanced Hepatocellular Carcinoma
Condition(s):Hepatocellular CancerLast Updated:March 1, 2010Unknown status
64
Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:December 20, 2018Completed
65
Ulinastatin Preventing Postoperative Hepatic Failure in Hepatocellular Carcinoma (HCC)
Condition(s):Hepatocellular CarcinomaLast Updated:March 30, 2016Completed
66
Study of the Combination of TACE With Apatinib in Patients With Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:February 23, 2017Unknown status
67
Stereotactic Radiation Therapy and Sorafenib in the Treatment of Hepatocellular Carcinoma
Condition(s):Hepatocellular Carcinoma; Liver CancerLast Updated:April 3, 2017Terminated
68
Study of Milciclib in Patients With Unresectable/Metastatic Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:September 10, 2019Active, not recruiting
69
Phase II Study of Concurrent Sorafenib and Intensity-modulated Radiotherapy (IMRT) for Advanced Hepatocellular Carcinoma
Condition(s):Hepatocellular Carcinoma, Radiotherapy, SorafenibLast Updated:October 11, 2019Recruiting
70
Genetic Polymorphisms of Interleukin-1B and TNF-A and HBV-Related Hepatocellular Carcinoma
Condition(s):Hepatitis B; Hepatocellular Carcinoma; Chronic Liver DiseaseLast Updated:April 17, 2013Completed
71
Long Term Follow-Up Study of Immuncell-LC Group and Non-Treatment Group in Hepatocellular Carcinoma Patients.
Condition(s):Hepatocellular CarcinomaLast Updated:August 3, 2016Completed
72
Radiofrequency Ablation Plus Radiotherapy for Small Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:June 17, 2019Not yet recruiting
73
Role of Choline PET/CT in Predicting Survival in Patients With Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:February 6, 2018Completed
74
A Study of DC-CIK to Treat Hepatocellular Carcinoma
Condition(s):Hepatocellular Carcinoma (HCC)Last Updated:April 11, 2013Unknown status
75
Stereotactic Body Radiation Therapy Combined With Anti-PD-1 Antibody in Patients With Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:March 17, 2019Recruiting
76
Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) and / or Microvascular Invasion
Condition(s):HepatoCellular CarcinomaLast Updated:July 8, 2018Recruiting
77
Immunotherapy of Hepatocellular Carcinoma by Induction of Anti-alpha Fetoprotein Response
Condition(s):Hepatocellular CarcinomaLast Updated:November 6, 2013Terminated
78
Perfusion and Dual Energy Computer Tomography in Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:March 21, 2019Recruiting
79
Liver Perfusion MRI With Quantification of Tumoral Perfusion for Early Assessment of the Response of Antiangiogenics Treatments in Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:August 31, 2017Terminated
80
Pilot Clinical Trial to Evaluate the UNI-DEB for Unresectable Hepatocellular Carcinoma
Condition(s):Hepatocellular Carcinoma Non-resectableLast Updated:June 19, 2018Completed
81
Anatomy-based Resection or Margin-based Resection for Hepatocellular Carcinoma
Condition(s):Hepatocellular Carcinoma by BCLC StageLast Updated:August 27, 2018Not yet recruiting
82
Clinical Trial to Evaluate the Efficacy and Safety of UNI-DEB for Unresectable Hepatocellular Carcinoma
Condition(s):Hepatocellular Carcinoma Non-resectableLast Updated:September 27, 2018Completed
83
Safety and Efficacy of Doxorubicin-eluting-bead Embolization in Patients With Advanced Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:January 15, 2018Active, not recruiting
84
A Prospective Randomized Trial Comparing Partial Hepatectomy and TACE Plus PEI for Small Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:March 30, 2016Completed
85
Statin for Preventing Hepatocellular Carcinoma Recurrence After Curative Treatment
Condition(s):HepatoCellular CarcinomaLast Updated:January 24, 2017Recruiting
86
Analysis of Expression of Specific Markers and Their Prognostic Significance in Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:May 25, 2017Completed
87
Study of TG02 Citrate in Patients With Advanced Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:September 23, 2019Withdrawn
88
Siliphos in Advanced Hepatocellular Carcinoma
Condition(s):Advanced Hepatocellular CarcinomaLast Updated:November 21, 2013Completed
89
Study of PIVKA-II and AFP Measurement in Surveillance Program for Early Detection of Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:January 14, 2011Unknown status
90
Environmental, Metabolic and Nutritional Factors of Hepatocellular Carcinoma in Cirrhotic Patients
Condition(s):Cirrhosis With Hepatocellular Carcinoma; Cirrhosis Without Hepatocellular CarcinomaLast Updated:July 28, 2016Unknown status
91
Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:June 22, 2017Unknown status
92
Chemoembolization of Non-resectable Non-metastatic Hepatocellular Carcinoma Using Embolization Microspheres
Condition(s):Localized Non-Resectable Adult Hepatocellular CarcinomaLast Updated:August 18, 2016Completed
93
Safety and Efficacy Study of Sintilimab Combined With IBI305 in Patients With Advanced Hepatocellular Carcinoma
Condition(s):Advanced Hepatocellular CarcinomaLast Updated:August 27, 2019Recruiting
94
Preoperative Estimation of Microvascular Invasion in Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:April 6, 2017Unknown status
95
Evaluate the Treatment With Sintilimab Injection Plus Endostar in Hepatocellular Carcinoma
Condition(s):Hepatocellular Carcinoma Non-resectableLast Updated:March 16, 2019Recruiting
96
Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:March 15, 2014Completed
97
A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:October 11, 2019Recruiting
98
Lenvatinib Plus Nivolumab Versus Lenvatinib for Advanced Hepatocellular Carcinoma With Hepatitis B Virus Infection
Condition(s):Hepatocellular CarcinomaLast Updated:October 20, 2019Not yet recruiting
99
Recurrence and Distant Metastases in Hepatocellular Carcinoma Treated by Transcatheter Arterial Chemoembolization
Condition(s):Hepatocellular CarcinomaLast Updated:February 1, 2009Completed
100
Study of Efficacy and Safety INC280 in Patients With Advanced Hepatocellular Carcinoma
Condition(s):Advanced Hepatocellular CarcinomaLast Updated:August 30, 2016Withdrawn